Discover How Helix is Changing the World of Healthcare
Resource Hub
Filters
Helix Debuts Novel Precision Effectiveness Model That Predicts 12-Month Weight Loss Response of Semaglutide in Diverse Populations
American Society of Human Genetics 2024 Posters
Building a Precision Medicine Enterprise Strategy
A novel method for predicting Lp(a) levels from routine outpatient genomic testing identifies those at risk of cardiovascular disease across a diverse cohort
Influence of BMI-associated genetic variants and metabolic risk factors on weight loss with semaglutide: a longitudinal clinico-genomic cohort study
Helix to Showcase the Impact of Clinico-Genomic Research on Clinical Care and Drug Discovery at ASHG Annual Meeting
Exploring Genomics: The Future of Personalized Health
Performance and Applications of Helix Exome+® Assay
Helix and WakeMed to Launch Major Genetic Health Initiative in Wake County
Screening Familial Risk for Hereditary Breast and Ovarian Cancer
Reduced Likelihood of Hospitalization With the JN.1 or HV.1 Severe Acute Respiratory Syndrome Coronavirus 2 Variants Compared With the EG.5 Variant
The Ohio State University Wexner Medical Center and Helix Partner to Launch the Largest Precision Health Initiative in Ohio
Technical Briefing: Semaglutide and Weight Management
Helix and Recursion Pharmaceuticals Drive Drug Discovery Innovation Through Clinico-Genomic Data
The Latest Content From Helix
Recent Blog Posts
View All Blog Posts
Blog
Population Genomics: Personalizing Genetic Breast Cancer Screening
Blog
Unraveling the Power of Germline Clinico-Genomic Data: A Game Changer in Pharma's Drug Development Lifecycle
Blog
Preventable hospitalizations with increased oral SARS-CoV-2 antiviral treatment
Blog
What You Need to Know About the Newly Updated ASCO-SSO Guidelines
Recent Press Releases
View All Press ReleasesPress Releases
Helix Debuts Novel Precision Effectiveness Model That Predicts 12-Month Weight Loss Response of Semaglutide in Diverse Populations
Press Releases
Helix to Showcase the Impact of Clinico-Genomic Research on Clinical Care and Drug Discovery at ASHG Annual Meeting
Press Releases
Helix and WakeMed to Launch Major Genetic Health Initiative in Wake County
Recent Videos
View All Videos
Recent Published Research
View All Published Research1
Published Research
Underestimated risk of secondary complications in pathogenic and glucose-elevating GCK variant carriers with type 2 diabetes
2
Published Research
Helix Debuts Novel Precision Effectiveness Model That Predicts 12-Month Weight Loss Response of Semaglutide in Diverse Populations
3
Published Research
A novel method for predicting Lp(a) levels from routine outpatient genomic testing identifies those at risk of cardiovascular disease across a diverse cohort
4
Published Research
Influence of BMI-associated genetic variants and metabolic risk factors on weight loss with semaglutide: a longitudinal clinico-genomic cohort study
5
Published Research